SECURED CONVERTIBLE FACILITY AGREEMENTSecured Convertible Facility Agreement • August 14th, 2020 • AgeX Therapeutics, Inc. • Pharmaceutical preparations • England and Wales
First Amendment to Secured Convertible Facility Agreement (this “Amendment”) by and between AgeX Therapeutics Inc., a Delaware corporation (“Borrower”) and Juvenescence Limited, a British Virgin Islands company (“Lender”) is effective as of July 21, 2020 (“Effective Date”).
SECURED CONVERTIBLE FACILITY AGREEMENTSecured Convertible Facility Agreement • March 15th, 2023 • AgeX Therapeutics, Inc. • Pharmaceutical preparations • England and Wales
This Third Amendment to Secured Convertible Facility Agreement (this “Amendment”) by and between AgeX Therapeutics Inc., a Delaware corporation (“Borrower”) and Juvenescence Limited, a company incorporated in the Isle of Man with company number 018008V and its registered office at 1st Floor Viking House, St Pauls Square, Ramsey, Isle of Man, IM8 1GB (“Lender”) is effective as of March 10, 2023 (“Effective Date”).
SECOND AMENDMENT TO SECURED CONVERTIBLE FACILITY AGREEMENTSecured Convertible Facility Agreement • November 16th, 2020 • AgeX Therapeutics, Inc. • Pharmaceutical preparations • England and Wales
This Second Amendment to Secured Convertible Facility Agreement (this “Amendment”) by and between AgeX Therapeutics Inc., a Delaware corporation (“Borrower”) and Juvenescence Limited, an Isle of Man company (“Lender”) is effective as of November 12th, 2020 (“Effective Date”).
